StockTipsArenaBeta

BUY Dr. Reddy's Laboratories Limited — Prakash Gaba

BUYDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

byPrakash GabaHorizon: NA (inferred Intraday)21 Oct 2026, 7:18 am ISTvia CNBC Awaaz.

Entry₹1,245Inferred
Target₹1,260
Total upside +1.20% (call closed)
Stop loss₹1,232-1.04% risk
At expiry₹1,24121 Oct 2026, 3:05 pm
Expired-0.32%
Follow Prakash Gaba for new calls(19% target hit, 375 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 21 Oct 2026
4 supporting1 neutral0 opposing
Supports the BUY call (4)

Dr Reddy's gets DGCI clearance for Zytorvi; Here's how company shares reacted

NewsCnbc-Tv18·21 Oct · today

(opens in new tab)

Dr. Reddy's received DCGI approval for Zytorvi (toripalimab) to treat advanced esophageal squamous cell carcinoma in India.

NSE · Press Release·21 Oct · today

(opens in new tab)

Dr. Reddy's Laboratories received approval from the DCGI for Zytorvi (toripalimab) in combination with chemotherapy for the treatment of advanced esophageal squamous cell carcinoma in India.

BSE · Company Update·21 Oct · today

(opens in new tab)

3 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·21 Oct · today

Neutral / worth noting (1)

Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select players

NewsEt-Markets·19 Oct · 2d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Prakash Gaba

Every call and its outcome